Clinical Trial Update: Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for DS010 in cancer cachexia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia
• Cancer

Drugs mentioned

• DS010 (DS010)

Snippet

Sponsor: Dartsbio Pharmaceuticals Ltd. | Conditions: Cancer, Cachexia | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING